TWi Biotechnology, Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 66.397 million compared to TWD 1.246 million a year ago. Operating income was TWD 25.147 million compared to operating loss of TWD 46.011 million a year ago. Net income was TWD 25.058 million compared to net loss of TWD 45.660 million a year ago. Basic earnings per share was TWD 0.37 compared to basic loss per share of TWD 0.68 a year ago.